These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28927802)

  • 1. Synthesis and biological evaluation of an
    Kimura H; Fujita N; Kanbe K; Matsuda H; Watanabe H; Arimitsu K; Fujimoto H; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2017 Oct; 25(20):5772-5778. PubMed ID: 28927802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of
    Kimura H; Matsuda H; Ogawa Y; Fujimoto H; Toyoda K; Fujita N; Arimitsu K; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2017 Feb; 25(4):1406-1412. PubMed ID: 28089587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
    Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
    J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
    Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
    J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis.
    Joosten L; Brom M; Peeters H; Bos D; Himpe E; Bouwens L; Boerman O; Gotthardt M
    Mol Pharm; 2019 Sep; 16(9):4024-4030. PubMed ID: 31345042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.
    Murakami T; Fujimoto H; Inagaki N
    Front Endocrinol (Lausanne); 2021; 12():714348. PubMed ID: 34248856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT.
    Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Matsumoto K; Inagaki N
    Endocrinology; 2019 Dec; 160(12):2959-2968. PubMed ID: 31613319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging.
    Joosten L; Brom M; Peeters H; Heskamp S; Béhé M; Boerman O; Gotthardt M
    Mol Pharm; 2018 Feb; 15(2):486-494. PubMed ID: 29226686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.
    Bauman A; Valverde IE; Fischer CA; Vomstein S; Mindt TL
    J Nucl Med; 2015 Oct; 56(10):1569-74. PubMed ID: 26251418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Quantification of the Beta Cell Mass after Pancreas Visualization with
    van der Kroon I; Joosten L; Nock BA; Maina T; Boerman OC; Brom M; Gotthardt M
    Mol Pharm; 2016 Oct; 13(10):3478-3483. PubMed ID: 27537699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendin.
    Brom M; Woliner-van der Weg W; Joosten L; Frielink C; Bouckenooghe T; Rijken P; Andralojc K; Göke BJ; de Jong M; Eizirik DL; Béhé M; Lahoutte T; Oyen WJ; Tack CJ; Janssen M; Boerman OC; Gotthardt M
    Diabetologia; 2014 May; 57(5):950-9. PubMed ID: 24488022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with
    Hamamatsu K; Fujimoto H; Fujita N; Murakami T; Shiotani M; Toyoda K; Inagaki N
    Sci Rep; 2019 Dec; 9(1):18338. PubMed ID: 31797889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of novel gonadotropin-releasing hormone receptor-targeting peptides.
    Guo H; Lu J; Hathaway H; Royce ME; Prossnitz ER; Miao Y
    Bioconjug Chem; 2011 Aug; 22(8):1682-9. PubMed ID: 21749045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
    Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
    Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences in pancreatic binding of DO3A-VS-Cys
    Eriksson O; Rosenström U; Selvaraju RK; Eriksson B; Velikyan I
    Acta Diabetol; 2017 Nov; 54(11):1039-1045. PubMed ID: 28891030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive longitudinal quantification of β-cell mass with [
    Fujita N; Fujimoto H; Hamamatsu K; Murakami T; Kimura H; Toyoda K; Saji H; Inagaki N
    FASEB J; 2019 Nov; 33(11):11836-11844. PubMed ID: 31370679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.
    Wicki A; Wild D; Storch D; Seemayer C; Gotthardt M; Behe M; Kneifel S; Mihatsch MJ; Reubi JC; Mäcke HR; Christofori G
    Clin Cancer Res; 2007 Jun; 13(12):3696-705. PubMed ID: 17575235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist.
    Connolly BM; Vanko A; McQuade P; Guenther I; Meng X; Rubins D; Waterhouse R; Hargreaves R; Sur C; Hostetler E
    Mol Imaging Biol; 2012 Feb; 14(1):79-87. PubMed ID: 21394533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Evaluation of GIP Effects on β-Cell Mass Under High-Fat Diet.
    Kiyobayashi S; Murakami T; Harada N; Fujimoto H; Murata Y; Fujita N; Hamamatsu K; Ikeguchi-Ogura E; Hatoko T; Lu X; Yamane S; Inagaki N
    Front Endocrinol (Lausanne); 2022; 13():921125. PubMed ID: 35909510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats.
    Mikkola K; Yim CB; Fagerholm V; Ishizu T; Elomaa VV; Rajander J; Jurttila J; Saanijoki T; Tolvanen T; Tirri M; Gourni E; Béhé M; Gotthardt M; Reubi JC; Mäcke H; Roivainen A; Solin O; Nuutila P
    Mol Imaging Biol; 2014 Apr; 16(2):255-63. PubMed ID: 24101374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.